University Of Notre Dame Du Lac Tricida, Inc. Transaction History

University Of Notre Dame Du Lac

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$18.43 - $38.04 $491,306 - $1.01 Million	-26,658 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$29.6 - $43.71 $18,233 - $26,925	-616 Reduced 2.26%	26,658 $1.01 Million
Q3 2019 Nov 13, 2019	SELL	$29.87 - $42.22 $2.25 Million - $3.18 Million	-75,222 Reduced 73.39%	27,274 $842,000
Q2 2019 Aug 14, 2019	BUY	$31.16 - $39.46 $3.19 Million - $4.04 Million	102,496 New	102,496 $4.04 Million

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of University Of Notre Dame Du Lac, based on Form 13F filings with the SEC.

Stay updated on University Of Notre Dame Du Lac with notifications on news.